Notice of Intent to Publish a Funding Opportunity Announcement for Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)

forecasted

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to solicit applications for Cystic Fibrosis (CF) Research and Translation Centers. CF Research and Translation Centers are designed to support both basic and clinical research on Cystic Fibrosis. CF Research and Translation Centers support three primary research-related activities: Research Core services; a Pilot and Feasibility program; and an Administrative Core with an enrichment program. These CF Centers provide shared resources to support research to develop and test new therapies for CF and to foster collaborations among institutions with a strong existing research base in CF. The NIDDK currently supports seven CF Research and Translation Centers located at institutions with documented programs of research excellence in basic and clinical CF Research. Information about the currently funded CF Research and Translation Centers may be found at: https://www.niddk.nih.gov/research-funding/research-programs/cystic-fibrosis-research-translation-centers or https://www.cysticfibrosiscenters.org/. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.� The NOFO is expected to be published in April 2024 with an expected application due date in July 2024. This NOFO will utilize the P30 activity code. Details of the planned NOFO are provided below.